Literature DB >> 19555288

Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies.

Kristine B Patterson1, Susan E Cohn, Jennifer Uyanik, Michael Hughes, Marlene Smurzynski, Joseph J Eron.   

Abstract

Menopause may affect antiretroviral treatment (ART) response. Immunologic and virologic responses to ART were compared in 220 premenopausal and 47 postmenopausal women enrolled in 2 studies involving ART-naive persons. Changes in CD4 counts or human immunodeficiency virus type 1 RNA levels were similar at 24, 48, and 96 weeks after treatment initiation. ART-naive women should respond to ART regardless of menopausal status.

Entities:  

Mesh:

Year:  2009        PMID: 19555288      PMCID: PMC2712125          DOI: 10.1086/600398

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Antiretroviral treatment and advanced age: epidemiologic, laboratory, and clinical features in the elderly.

Authors:  Roberto Manfredi; Leonardo Calza; Davide Cocchi; Francesco Chiodo
Journal:  J Acquir Immune Defic Syndr       Date:  2003-05-01       Impact factor: 3.731

Review 2.  Clinical pharmacokinetics of cerivastatin.

Authors:  W Mück
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

3.  Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

Authors:  Roy M Gulick; Heather J Ribaudo; Cecilia M Shikuma; Christina Lalama; Bruce R Schackman; William A Meyer; Edward P Acosta; Jeffrey Schouten; Kathleen E Squires; Christopher D Pilcher; Robert L Murphy; Susan L Koletar; Margrit Carlson; Richard C Reichman; Barbara Bastow; Karin L Klingman; Daniel R Kuritzkes
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

4.  Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients.

Authors:  G Orlando; P Meraviglia; L Cordier; L Meroni; S Landonio; R Giorgi; M Fasolo; I Faggion; A Riva; A Zambelli; R Beretta; G Gubertini; G Dedivitiis; G Jacchetti; A Cargnel
Journal:  HIV Med       Date:  2006-11       Impact factor: 3.180

Review 5.  Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras.

Authors:  Maria Prins; Laurence Meyer; Nancy A Hessol
Journal:  AIDS       Date:  2005-03-04       Impact factor: 4.177

6.  Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.

Authors:  Roy M Gulick; Heather J Ribaudo; Cecilia M Shikuma; Stephanie Lustgarten; Kathleen E Squires; William A Meyer; Edward P Acosta; Bruce R Schackman; Christopher D Pilcher; Robert L Murphy; William E Maher; Mallory D Witt; Richard C Reichman; Sally Snyder; Karin L Klingman; Daniel R Kuritzkes
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

7.  Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2003-09-01       Impact factor: 3.731

8.  Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy.

Authors:  K Patterson; S Napravnik; J Eron; J Keruly; R Moore
Journal:  HIV Med       Date:  2007-09       Impact factor: 3.180

9.  Gender difference in HIV RNA levels: a meta-analysis of published studies.

Authors:  Sonia Napravnik; Charles Poole; James C Thomas; Joseph J Eron
Journal:  J Acquir Immune Defic Syndr       Date:  2002-09-01       Impact factor: 3.731

10.  Cost-effectiveness of HIV screening in patients older than 55 years of age.

Authors:  Gillian D Sanders; Ahmed M Bayoumi; Mark Holodniy; Douglas K Owens
Journal:  Ann Intern Med       Date:  2008-06-17       Impact factor: 25.391

View more
  9 in total

1.  Age Differences by Sex in Antiretroviral-Naïve Participants: Pooled Analysis from Randomized Clinical Trials.

Authors:  LaRee A Tracy; Kimberly Struble; Cynthia Firnhaber; Laura Smeaton; Jordan E Lake; Tanvir Bell; Guoxing Gregg Soon; Jin Yan; Kathryn Schnippel; Susan E Cohn
Journal:  J Assoc Nurses AIDS Care       Date:  2018-02-02       Impact factor: 1.354

Review 2.  HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral Therapy.

Authors:  Kentaro Imai; Madeline Y Sutton; Rennatus Mdodo; Carlos Del Rio
Journal:  Obstet Gynecol Int       Date:  2013-12-19

3.  The menopause transition in women living with HIV: current evidence and future avenues of research.

Authors:  Shema Tariq; Jane Anderson; Fiona Burns; Valerie Delpech; Richard Gilson; Caroline Sabin
Journal:  J Virus Erad       Date:  2016-04-01

4.  Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy.

Authors:  Luuk Gras; Margaret May; Lars Peter Ryder; Adam Trickey; Marie Helleberg; Niels Obel; Rodolphe Thiebaut; Jodie Guest; John Gill; Heidi Crane; Viviane Dias Lima; Antonella dʼArminio Monforte; Timothy R Sterling; Jose Miro; Santiago Moreno; Christoph Stephan; Colette Smith; Janet Tate; Leah Shepherd; Mike Saag; Armin Rieger; Daniel Gillor; Matthias Cavassini; Marta Montero; Suzanne M Ingle; Peter Reiss; Dominique Costagliola; Ferdinand W N M Wit; Jonathan Sterne; Frank de Wolf; Ronald Geskus
Journal:  J Acquir Immune Defic Syndr       Date:  2019-03-01       Impact factor: 3.731

Review 5.  Menopause care in women living with HIV in the UK - A review.

Authors:  B Dragovic; J Rymer; N Nwokolo
Journal:  J Virus Erad       Date:  2022-02-15

Review 6.  Caring for women living with HIV: gaps in the evidence.

Authors:  Mona R Loutfy; Lorraine Sherr; Ulrike Sonnenberg-Schwan; Sharon L Walmsley; Margaret Johnson; Antonella d'Arminio Monforte
Journal:  J Int AIDS Soc       Date:  2013-10-01       Impact factor: 5.396

7.  Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil.

Authors:  Guilherme Amaral Calvet; Luciane Velasque; Paula Mendes Luz; Sandra Wagner Cardoso; Monica Derrico; Ronaldo Ismério Moreira; Angela Cristina Vasconcelos de Andrade; Andrea Cytryn; Elaine Pires; Valdiléa Gonçalves Veloso; Beatriz Grinsztejn; Ruth Khalili Friedman
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

Review 8.  Perspectives on menopause and women with HIV.

Authors:  Nisha Andany; V Logan Kennedy; Muna Aden; Mona Loutfy
Journal:  Int J Womens Health       Date:  2016-01-11

9.  Low-level genital HIV shedding in Thai HIV-infected women with suppressed plasma viral load after menopause: a longitudinal study.

Authors:  Nadia Kancheva Landolt; Tanya Do; Naruporn Kasipong; Rosalin Kriengsinyot; Sasiwimol Ubolyam; Apicha Mahanontharit; Tippawan Pankam; Tanakorn Apornpong; Anchalee Avihingsanon; Jintanat Ananworanich; Nittaya Phanuphak; Surasith Chaithongwongwatthana
Journal:  J Virus Erad       Date:  2017-10-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.